These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 30504413)

  • 1. Efficacy of Enteral Access in Patients with Esophageal Squamous Cell Carcinoma Under Neoadjuvant Therapy.
    Huang CH; Wang TF; Wu YF; Cheng YT; Lo SF; Hsieh TC; Peng TC
    Anticancer Res; 2018 Dec; 38(12):6939-6945. PubMed ID: 30504413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enteral Access is not Required for Esophageal Cancer Patients Undergoing Neoadjuvant Therapy.
    Huerter ME; Charles EJ; Downs EA; Hu Y; Lau CL; Isbell JM; McMurry TL; Kozower BD
    Ann Thorac Surg; 2016 Sep; 102(3):948-954. PubMed ID: 27209608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enteral Access Potentially Endangers Esophageal Carcinoma Patients Under Multi-modality Therapy: A Population-based Study.
    Huang CH; Hsieh TC; Chang BS; Wang TF; Wu JL; Chang PC; Peng TC
    Anticancer Res; 2019 Apr; 39(4):2227-2232. PubMed ID: 30952771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Clinical Markers of Nutritional Status and Feeding Jejunostomy Use on Outcomes in Esophageal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.
    Jain R; Shaikh T; Yee JL; Au C; Denlinger CS; Handorf E; Meyer JE; Dotan E
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33080840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutritional support with endoluminal stenting during neoadjuvant therapy for esophageal malignancy.
    Bower M; Jones W; Vessels B; Scoggins C; Martin R
    Ann Surg Oncol; 2009 Nov; 16(11):3161-8. PubMed ID: 19636630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Nutritional Status in the Treatment Outcome for Esophageal Squamous Cell Carcinoma.
    Chen MF; Hsieh CC; Chen PT; Lu MS
    Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Significance of Low Body Mass Index and Betel-Quid Use in the 5-Year Survival Rates of Esophageal Squamous Cell Carcinoma Patients.
    Pan YP; Hsu TY; Lin JY; Ho CJ; Kuan CY; Chou WC; Lai CH; Chang PH; Yeh KY
    Nutr Cancer; 2018; 70(8):1315-1321. PubMed ID: 30900908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Sarcopenia and Clinical Outcomes in Patients With Esophageal Cancer Under Neoadjuvant Therapy.
    Huang CH; Lue KH; Hsieh TC; Liu SH; Wang TF; Peng TC
    Anticancer Res; 2020 Feb; 40(2):1175-1181. PubMed ID: 32014971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enteral nutrition and quality of life in patients undergoing chemoradiotherapy for esophageal carcinoma: a comparison of nasogastric tube, esophageal stent, and ostomy tube feeding.
    Yu FJ; Shih HY; Wu CY; Chuang YS; Lee JY; Li HP; Fang PT; Tsai DL; Chou SH; Wu IC
    Gastrointest Endosc; 2018 Jul; 88(1):21-31.e4. PubMed ID: 29225081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-expanding plastic esophageal stents versus jejunostomy tubes for the maintenance of nutrition during neoadjuvant chemoradiation therapy in patients with esophageal cancer: a retrospective study.
    Siddiqui AA; Glynn C; Loren D; Kowalski T
    Dis Esophagus; 2009; 22(3):216-22. PubMed ID: 19207544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of self-expanding removable metal esophageal stents during neoadjuvant chemotherapy for resectable esophageal cancer.
    Pellen MG; Sabri S; Razack A; Gilani SQ; Jain PK
    Dis Esophagus; 2012 Jan; 25(1):48-53. PubMed ID: 21595778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Dysphagia in Esophageal Adenocarcinoma Patients Undergoing Neoadjuvant Chemotherapy: Can Invasive Tube Feeding be Avoided?
    Cools-Lartigue J; Jones D; Spicer J; Zourikian T; Rousseau M; Eckert E; Alcindor T; Vanhuyse M; Asselah J; Ferri LE
    Ann Surg Oncol; 2015; 22(6):1858-65. PubMed ID: 25476030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enteral feeding in head and neck cancer patients at a UK cancer centre.
    Sheth CH; Sharp S; Walters ER
    J Hum Nutr Diet; 2013 Oct; 26(5):421-8. PubMed ID: 23379517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-Expanding Metal Stents Improve Swallowing and Maintain Nutrition During Neoadjuvant Therapy for Esophageal Cancer.
    Smith ZL; Gonzaga JE; Haasler GB; Gore EM; Dua KS
    Dig Dis Sci; 2017 Jun; 62(6):1647-1656. PubMed ID: 28391413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT
    Tang H; Tan L; Shen Y; Wang H; Lin M; Feng M; Xu S; Guo W; Qian C; Liu T; Zeng Z; Hou Y; Yu Z; Jiang H; Li Z; Chen C; Lian C; Du M; Li H; Xie D; Yin J; Zhao N; Wang Q
    BMC Cancer; 2017 Jun; 17(1):450. PubMed ID: 28659128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A disease-specific enteral nutrition formula improves nutritional status and functional performance in patients with head and neck and esophageal cancer undergoing chemoradiotherapy: results of a randomized, controlled, multicenter trial.
    Fietkau R; Lewitzki V; Kuhnt T; Hölscher T; Hess CF; Berger B; Wiegel T; Rödel C; Niewald M; Hermann RM; Lubgan D
    Cancer; 2013 Sep; 119(18):3343-53. PubMed ID: 23765693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant versus adjuvant chemoradiation for stage II-III esophageal squamous cell carcinoma: a single institution experience.
    Chen Y; Hao D; Wu X; Xing W; Yang Y; He C; Wang W; Liu J; Wang J
    Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in body composition secondary to neoadjuvant chemotherapy for advanced esophageal cancer are related to the occurrence of postoperative complications after esophagectomy.
    Ida S; Watanabe M; Karashima R; Imamura Y; Ishimoto T; Baba Y; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Baba H
    Ann Surg Oncol; 2014 Oct; 21(11):3675-9. PubMed ID: 24793436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits of Supplemental Jejunostomy Tube Feeding During Neoadjuvant Therapy in Patients with Locally Advanced, Potentially Resectable Esophageal Cancer.
    Dalton BGA; Friedant AJ; Su S; Schatz TAP; Ruth KJ; Scott WJ
    J Laparoendosc Adv Surg Tech A; 2017 Dec; 27(12):1279-1283. PubMed ID: 28777676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enteral Nutrition Support Does Not Improve PNI in Radiotherapy Patients with Locally Advanced Esophageal Cancer.
    Ye Y; Xu Y; Fu Q; Shen P; Chen Y; Zheng P; Song L; Chen Y; Wang J
    Nutr Cancer; 2019; 71(2):223-229. PubMed ID: 30663378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.